Vulvovaginal atrophy (VVA) accompanies the natural aging of a woman and her vagina and affects up to 80% of women after menopause. CO₂ lasers have recently been developed to address VVA symptoms in women, and these treatments have been shown to significantly relieve some of these symptoms. Femtouch can help women who are on long term treatments with tamoxifen or similar agents without introducing hormone creams, which could theoretically increase their long term risk of cancer returning.

Femtouch™ is an innovative state-of-the-art CO₂ laser technology treatment that is applied along the vaginal walls and delivers a very gentle and controlled ablation and coagulation of the vaginal lining addressing common vaginal health related issues and improving Women’s health. This is a minimally invasive fractional scanning procedure, delivering a continuous wave of fractional energy that provides uniform coverage along the vaginal wall. The microbeam penetration into the lamina propria is controlled using the available settings, which range from 7.5-12.5 mJ.